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 Studies of bioinformatics develop methods and software tools to analyze the 
biological data and provide insight of the mechanisms of biological process. Machine 
learning techniques have been widely used by researchers for disease prediction, disease 
diagnosis, and bio-marker identification. Using machine-learning algorithms to diagnose 
diseases has a couple of advantages. Besides solely relying on the doctors’ experiences and 
stereotyped formulas, researchers could use learning algorithms to analyze sophisticated, 
high-dimensional and multimodal biomedical data, and construct prediction/classification 
models to make decisions even when some information was incomplete, unknown, or 
contradictory. In this study, first of all, we built an automated computational pipeline to 
reconstruct phylogenies and ancestral genomes for two high-resolution real yeast whole 
genome datasets. Furthermore, we compared the results with recent studies and 
publications to show that we reconstruct very accurate and robust phylogenies, as well as 
ancestors. We also identified and analyzed conserved syntenic blocks among reconstructed 
ancestral genomes and present yeast species.  
Next, we analyzed the metabolic level dataset obtained from positive mass 
spectrometry of human blood samples. We applied machine learning algorithms and 
feature selection algorithms to construct diagnosis models of Chronic kidney diseases 
(CKD). We also identified the most critical metabolite features and studied the correlations 
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among the metabolite features and the developments of CKD stages. The selected 
metabolite features provided insights into CKD early stage diagnosis, pathophysiological 
mechanisms, CKD treatments, and medicine development.  
Finally, we used deep learning techniques to build accurate Down Syndrome (DS) 
prediction/screening models based on the analysis of newly introduced Illumina human 
genome genotyping array. We proposed a bi-stream convolutional neural network (CNN) 
architecture with ten layers and two merged CNN models, which took two input 
chromosome SNP maps in combination. We evaluated and compared the performances of 
our CNN DS predictions models with conventional machine learning algorithms. We 
visualized the feature maps and trained filter weights from intermediate layers of our 
trained CNN model. We further discussed the advantages of our method and the underlying 
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CHAPTER 1  
INTRODUCTION 
 
1.1 RELATED STUDIES ON PHYLOGENY AND ANCESTRAL GENOME 
RECONSTRUCTION 
Phylogenetic studies used to be the domain of morphological area and were based 
on outward appearances and internal structures (Snodgrass, 1938). Later on, molecular 
characters and DNA sequencing technologies had augmented these studies in building 
robust phylogenies (Frickey & Lupas, 2004; Höhl & Ragan, 2007), however, different 
methods often yielded conflicting phylogeny results (Hedtke, Townsend, & Hillis, 2006; 
Marcet-Houben & Gabaldón, 2015; Rokas, King, Finnerty, & Carroll, 2003; Salichos & 
Rokas, 2013; Vakirlis et al., 2016). Local and biased sequences may not be enough to         
conflicting phylogenetic signals. Currently, the widely accepted phylogenetic approach to 
alleviate these conflicting issues is to analyze shared gene datasets, and 
concatenate/coalesce their results from multiple sequence alignments to obtain a final 
phylogeny with the maximum support (Marcet-Houben & Gabaldón, 2015; Salichos & 
Rokas, 2013; Vakirlis et al., 2016). Recently, Salichos et al. analyzed a yeast gene dataset 
with 1,070 orthologs from 23 species and discovered 1,070 phylogenies. They 
concatenated these results into a final phylogeny with the maximum likelihood (Salichos 
 
 2 
& Rokas, 2013). Marcet-Houben and Vakirlis also used similar approaches to build yeast 
phylogenies for 19 and 34 species (Marcet-Houben & Gabaldón, 2015; Vakirlis et al., 
2016). Nevertheless, contradictories still exist among these studies. These conflicting 
phylogenies could be caused by method inconsistency, compositional bias, alignment 
ambiguity, model misspecification, and long branches attraction (Hedtke et al., 2006; 
Salichos & Rokas, 2013).  
Genome-level evolutionary events and their biological significances have been 
studied for 80 years (Sturtevant & Dobzhansky, 1936). Computational methods were 
developed in 1990s (Blanchette, Bourque, & Sankoff, 1997; Sankoff & Blanchette,1997). 
Since then, computational methods were widely explored in phylogeny reconstructions and 
evolutionary mechanisms in the past three decades (Avdeyev, Jiang, Aganezov, Hu, & 
Alekseyev, 2016; Ma, 2010; Perrin, Varré, Blanquart, & Ouangraoua, 2015; Sankoff, 2009; 
Sankoff & Zheng, 2013; Xu & Moret, 2011). The availability of fully sequenced/annotated 
genomes and advanced computational algorithms have brought evolutionary studies going 
beyond the mere sequence level (Boore, 2006; Fertin, 2009). Gene orders can be used as 
genome markers in genome level evolutionary studies (Delsuc, Brinkmann, & Philippe, 
2005). They represent the genome content, gene permutations, and gene directions, which 
can reflect genome content and structural variations during evolution. Gene order-based 
phylogeny reconstruction approaches obtain phylogenetic signals from genome level 
evolutionary events and can bypass the troublesome multiple sequence alignment step in 
traditional methods (Boore, 2006; Fertin, 2009; Lin, Hu, Tang, & Moret, 2013). However, 
gene order level phylogenetic studies are more computationally costly when compared with 
traditional sequence level studies. Because researchers usually treat all gene order 
permutations for a special occasion as a single character out of billions of possible 
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permutation states (Avdeyev et al., 2016; Fertin, 2009; Hu, Zhou, Zhou, & Tang, 2014; 
Vakirlis et al., 2016; L. Zhou, Hoskins, Zhao, & Tang, 2015).  
Researchers have been working on the computational approaches for phylogeny 
and ancestral reconstructions on whole genome level data (Avdeyev et al., 2016; Gagnon, 
Blanchette, & El-Mabrouk, 2012; Gao, Zhang, Feng, & Tang, 2015; Lin et al., 2013; 
Sankoff & Zheng, 2013; Xu & Moret, 2011; J. Zhou et al., 2016; L. Zhou et al., 2015; L. 
Zhou, Lin, Feng, Zhao, & Tang, 2016). Most present approaches can only handle simplified 
real genome datasets or simulated datasets with identical genome content and unique 
genome markers (Alekseyev & Pevzner, 2009; Feijão & Meidanis, 2009; Hu, Zhou, & 
Tang, 2013; Ma, 2010; Perrin et al., 2015; Xu & Moret, 2011; Zheng & Sankoff, 2011). 
So that they cannot be applied to the original real genome data without modifications. They 
are also restricted by handling complex evolutionary events, such as deletion, insertion, 
and duplication (Avdeyev et al., 2016; Feijão & Meidanis, 2009; Feng, Zhou, & Tang, 
2017; Ma, 2010; Perrin et al., 2015; Xu & Moret, 2011; L. Zhou et al., 2015). Some recent 
studies used the modified real genome datasets to build phylogenies, by removing non-
shared genes (Luo et al., 2012) or using mitochondrial data (Figueroa & Baco, 2015; 
Weigert et al., 2016). For current computational ancestral reconstruction methods, only 
ANGES (Jones, Rajaraman, Tannier, & Chauve, 2012), Gapped Adjacency (Gagnon et al., 
2012), and MGRA2 (Avdeyev et al., 2016) are reported being able to hand non-identical 
genome content and all types of evolutionary events. However, they still suffer from issues 
of low-resolution, accuracy, and robustness. Recently, gene duplication events have also 
been considered in real genome ancestral reconstructions, but only for X-chromosome of 
six mammals (Rajaraman & Ma, 2016).  
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Yeasts have been used as models for higher level complex organisms, including 
mammals and humans (Bhargava, 2010). Whole-genome sequencing studies have shown 
that yeasts have similar genome sizes, gene contents, and collinearity of genes along the 
chromosomes of species (Wolfe, 2015). Gordon reconstructed the yeast ancestral genome 
that extinct 100 million years ago with a manual approach, using the gene order data of 11 
species in Yeast Genome Order Browser (YGOB) (http://ygob.ucd.ie) (Byrne & Wolfe, 
2005; Gordon, Byrne, & Wolfe, 2009). In the latest version of YGOB, Byrne and Wolfe 
added nine additional yeast species and reconstructed a ’benchmark’ version of yeast 
ancestral genome from 20 species using the same method (Byrne & Wolfe, 2005; Gordon 
et al., 2011). Jean proposed a computational method to reconstruct an ancestral genome for 
five non-WGD (Whole-genome duplication) species in YGOB (Jean, Sherman, & 
Nikolski, 2009). Chauve later developed a computational method to reconstruct an 
ancestral genome using the same dataset as Jean but with two genome marker sets (Chauve, 
Gavranovic, Ouangraoua, & Tannier, 2010). The “low-resolution marker set” contains the 
same 135 genome makers that were used by Jean. (Jean et al., 2009) The “high-resolution 
marker set” contains 710 genome markers (Chauve et al., 2010). However, their studies are 
still based on low-resolution datasets with only five species. Even the "high-resolution set" 
with 710 markers is still too low to reconstruct reliable ancestral architectures for current 
whole genome level studies. Vakirlis reconstructed yeast ancestral genomes from 10 non-
WGD species of the Lachancea genus. They annotated 3,598 orthologs among these 10 
species and considered each gene as a genome marker to reach the highest resolution. 
However, their studies are only limited in one non-WGD genus. (Vakirlis et al., 2016)  
Our group previously developed two computational phylogeny and ancestral 
reconstruction approaches, MLWD (Maximum Likelihood on Whole-genome Data) (Lin 
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et al., 2013) and PMAG (Probabilistic Method of Ancestral Genomics) (Hu et al., 2013). 
These approaches could only handle simulated data with identical genome content, unique 
genome markers, and limited types of evolutionary events. In this study, we redesigned the 
evolutionary models and innovated the algorithms for these two approaches. Our improved 
approaches now can handle real genome data, which have non-identical genome contents, 
non-unique genome markers, and all types of evolutionary events, including genome 
rearrangements, insertion, deletion, duplication, and whole genome duplication (WGD). 
Furthermore, we built an automated pipeline to reconstruct phylogenies and ancestral 
genomes for two high-resolution whole-genome datasets of the Saccharomycetaceae 
family. Finally, we identified and analyzed conserved syntenic blocks among reconstructed 
ancestors and present yeast species.   
1.2 RELATED STUDIES ON CKD SCREENING AND DIAGNOSIS 
Chronic Kidney Diseases (CKDs) are progressive losses and abnormalities of 
kidney functions and structures (Levey et al., 2005). Now they become major challenges 
to public health and affect approximately 10% of the population worldwide (Subasi, 
Alickovic, & Kevric, 2017). CKDs often result in Acute Kidney Injury (AKI), which 
appears abruptly and has rapid deterioration of kidney function (Bellomo, Kellum, & 
Ronco, 2012; Chawla, Eggers, Star, & Kimmel, 2014). The end-stage (stage 5) and AKI 
would cause renal failure and require special treatments such as dialysis and renal 
transplant (Bagshaw, Berthiaume, Delaney, & Bellomo, 2008). CKDs are also associated 
with other severe complications, including cardiovascular disease, hypertension, diabetes 
(Levey et al., 2003), cognitive decline, anemia, mineral and bone disorders, and fractures 
(Jha et al., 2013). CKD screening and stage detection are critical to the prognosis and 
interventions. Renal failure could have been reversed if the CKDs were detected and 
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treated in the early stage (Levey et al., 2003; Morton, Tong, Howard, Snelling, & Webster, 
2010). Prompt treatments and management for specific CKD stages can significantly 
prevent and delay the promotions and progressions of CKDs. (Jha et al., 2013; Levey et 
al., 2003; Morton et al., 2010). Meanwhile, CKDs in different stages require different 
management, treatments, and medicines (Coresh et al., 2007; Lameire & Van Biesen, 2010; 
Levey & Coresh, 2012). Proper management strategies can significantly reduce the 
incidence of end-stage CKDs. (Jha et al., 2013). However, the early stage of CKD (stage 
1) is hard to be recognized (Levey et al., 2013) because initially, no symptoms might be 
found. Treatments and management for CKD will not be made until symptoms become 
severe or accidental findings from tests for other diseases (Webster et al., 2017).  
Recent international guidelines classify CKDs into five stages based on the levels 
of glomerular filtration rate (GFR) (Levey et al., 2005, 2013). GFR is computed by 
estimating equations and other associated exogenous bio-factors (Webster et al., 2017). In 
fact, there are many issues in current GFR estimation approaches. The estimating equations 
may lead to inaccuracy due to the patient's’ personal situations including age, race, gender, 
and serum creatinine level (Levey et al., 2002, 2005; Levin et al., 2013). Moreover, various 
GFR estimating approaches and equations will result in disagreements and errors for the 
same patients (Bevc et al., 2017). Recent Bland-Altman analysis showed that the CKD-
EPI creatinine-cystatin C, BIS2, CKD-EPI cystatin C and Simple cystatin C GFR equations 
were all lacking accuracies in estimating GFR for elderly people (Bevc et al., 2017). 
Researchers also discovered that using the Schwartz formula to estimate GFR for children 
would result in overestimations (Levey et al., 2009). Muna et al. found that the BIS 
equation was not a proper approach to predict the risks of death for older women when 
compared with the CKD-EPI equations (Canales et al., 2017). These inaccurate and 
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contradictory issues in present GFR estimating approaches might result in misjudgement 
of CKD stages, which may cause further underdiagnoses and undertreatments (Levey et 
al., 2003). 
Using machine learning algorithms to diagnose diseases has a few advantages. 
Besides solely relying on the doctors’ experiences and stereotyped formulas, researchers 
could use learning algorithms to analyze sophisticated, high-dimensional and multimodal 
biomedical data, and construct prediction/classification models to make decisions even 
when some information was incomplete, unknown, or contradictory. Current machine-
learning based CKD diagnostic studies have shown high accuracies and reliabilities in 
CKDs detections and diagnoses (Polat, Mehr, & Cetin, 2017). Neves et al. used Artificial 
Neural Networks to build a classification model to classify 558 CKD and non-CKD 
patients based on 24 features, which achieved 92.3 % accuracy in testing (Neves et al., 
2015). Celik et al. used Decision Tree and Support Vector Machine (SVM) algorithms to 
classify a CKD dataset with 400 patients and 24 features, which both achieved accuracies 
over 96% in classifying the CKD and non-CKD patients (Celik, Atalay, & Kondiloglu, 
2016). Polat et al. used the SVM algorithm to classify the same CKD dataset used by Celik, 
which reached an accuracy of 98.5% (Polat et al., 2017). Chen et al applied three different 
learning algorithms to construct classification models for the datasets with CKD and non-
CKD patients, which all achieved accuracies over 93% (Chen, Zhang, & Zhang, 2016). 
However, most present CKD diagnosis machine learning studies performed only on small 
datasets with limited numbers of physiological features. They only focused on the simple 
yes/no problems but could not classify the different CKD stages (Celik et al., 2016; Neves 
et al., 2015; Polat et al., 2017)  
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1.3 RELATED STUDIES ON DOWN SYNDROME SCREENING 
Down syndrome (DS) is a genetic disorder caused by genome dosage imbalances 
and micro-duplications of human chromosome 21 (HSA21) (Antonarakis, 2016). It is 
usually associated with intellectual disability, congenital heart defects, childhood 
leukaemia, Alzheimer’s disease, early ageing, physical abnormalities, and other 
abnormalities (Antonarakis, 2016; Patterson, 2009; Wiseman, Alford, Tybulewicz, & 
Fisher, 2009) Even though DS happens at a high rate worldwide (1 per 1,000 live births) 
(Weijerman & De Winter, 2010), and has been well studied, researchers haven’t found any 
effective cure method. No environmental factors or parents’ behavioral factor has been 
discovered to cause the Human DS disease either (Parker et al., 2010). Currently, DS 
therapies in human studies mainly concentrate on early intervention, educational therapy 
(Guralnick, 2010; Wuang, Chiang, Su, & Wang, 2011), physical therapy (Chavez, 2016; 
Wentz, 2017), as well as emotional and behavioral therapies (Greenspan, Wieder, & 
Simons, 1998; Wuang et al., 2011). These therapies only have limited effects and can 
barely cure DS fundamentally. Therefore, Screening and early detection become the most 
efficient way of DS prevention.  
DS screening has been studied since 1960s. A few DS biomarkers have been 
discovered, such as alpha-fetoprotein levels, human chorion gonadotropin, and 
unconjugated estriol (Brock & Sutcliffe, 1972; Wald et al., 1988). Currently, the most 
widely used approaches for DS screening include ultrasound measurement of fetal nuchal 
translucency (Spencer, Souter, Tul, Snijders, & Nicolaides, 1999), blood test (Ehrich et al., 
2011), sequencing test (Palomaki et al., 2011), and combined genetic test (Driscoll & 
Gross, 2009). However, 1/16 DS screen test positive women are still suffering from further 
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high-risk invasive diagnostic procedures, such as amniocentesis and chorionic villus 
sampling, which both have a 1/200 chance to result in the fetal loss (Palomaki et al., 2011).  
Human chromosome 21 (Hsa21) encodes more than 500 genes (Higuera, Gardiner, & Cios, 
2015; Sturgeon & Gardiner, 2011), including protein modifiers, transcription factors, RNA 
splicing factors/modifiers, cell surface receptors and adhesion molecules, and components 
of many biochemical pathways (Dierssen & de la Torre, 2012; Higuera et al., 2015). 
However, only 165 genes are annotated as protein-coding genes or microRNAs. More than 
350 genes have unassigned functions (K. Gardiner et al., 2010).  Recent GWAS studies 
have discovered that the SNPs (Single-nucleotide polymorphisms) variation, copy number 
variations, and unidentified genetic variation are highly correlated with human DS (Jain et 
al., 2016; Petry et al., 2017; Ramachandran et al., 2015; Sailani et al., 2013). Illumina has 
introduced a new exome genotyping array technique that targets the exome plus rare single-
nucleotide polymorphisms (SNPs). The Vanderbilt Epidemiology Center and Center for 
Quantitative Sciences developed a chip–processing protocols and collected the clinical 
genotyping data for various diseases (Sailani et al., 2013).  
Mice models can be used to dissect the Hsa21 gene interactions and study the DS 
phenotype. Experimental pathway perturbations studies on the mouse model with 
segmental trisomy for Hsa21 provide unprecedented opportunity to decipher human DS 
pathway studies (K. Gardiner et al., 2010). Ts65Dn mice model has three copies of over 
half of the Hsa21 orthologs genes on chromosome 16 (Reinholdt et al., 2011), and it a 
widely used DS model of human DS (Kuehn, 2016). Some achievements have been 
accomplished in the DS therapies in mouse models. Laura et al found that prenatal 
treatments with NAPVSIPQ and SALLRSIPA could prevent developmental delay and glial 
deficit (Toso et al., 2008). Alexander et al discovered that Kcnj6 gene was a critical factor 
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in synaptic and cognitive dysfunction. Its reduction could restore the Kir3.2 hippocampal 
level to normal. (Kleschevnikov et al., 2017)  
Machine learning techniques have been used in diseases diagnosis, diseases related 
genetic disorder, and bio-marker predictions (Gray et al., 2013; Park & Kellis, 2015; Roth 
et al., 2016). Commonly used supervised learning methods include Conventional artificial 
neural network, Deep learning neural networks, Support vector machine (SVM) (Roth et 
al., 2016), random forest (Gray et al., 2013), decision tree (Anbarasi, Anupriya, & Iyengar, 
2010), and Bayesian classifiers (Schwarz, Rödelsperger, Schuelke, & Seelow, 2010). 
Recently, deep convolutional neural networks (CNN) and recurrent neural networks 
(RNN) have achieved impressive results in a variety of disease screening, diagnosis, and 
predictions problems (Esteva et al., 2017; Faust et al., 2016; Roth et al., 2016; Sun, Tseng, 
Zhang, & Qian, 2017). Based on our knowledge, only a few conventional machine learning 
techniques have been applied to human DS studies (Higuera et al., 2015). Most of them 
performed on DS mice model Ts65Dn (Higuera et al., 2015; Nguyen, Costa, Cios, & 
Gardiner, 2011; Sailani et al., 2013). Clara et al. analyzed the expression levels of 77 
proteins and designed an unsupervised self-organizing map to identify biological 
differences of DS mice model Ts65Dn (Higuera et al., 2015). Cao et al. used a naïve Bayes 
classifier to predict the level of locomotor activity under the treatments of the N-methyl-
D-aspartate receptor in mice models Ts65Dn and Ts1Cje (Nguyen et al., 2011). Zhao et al. 
proposed a hierarchical constrained local model with independent component analysis to 









PHYLOGENY AND ANCESTOR RECONSTRUCTION USING YEASTS 
GENOME DATA 
2.1 MOTIVATIONS 
Originally, studies of yeast phylogenies were based on morphological phenotypes 
and characters, such as sexual states, germinations, and fermentations (Kurtzman, Fell, & 
Boekhout, 2011). Currently, widely accepted yeasts phylogenetic approaches are based on 
multiple sequence alignment. However, there are still limitations and common conflicting 
results with each other (Hedtke et al., 2006; Marcet-Houben & Gabaldón, 2015; Salichos 
& Rokas, 2013; Vakirlis et al., 2016). Current whole genome level phylogenetic studies on 
real data are limited in simplified identical content genomes (Luo et al., 2012) and 
mitochondrial datasets (Figueroa & Baco, 2015; Weigert et al., 2016). In this study, we 
want to reconstruct the phylogenies for two high-resolution yeasts genome datasets by 
using phylogenetic signals from genome level evolutionary events. We will compare our 
results with the NCBI taxonomy and recent publications. We will provide a new and 
alternative method to resolve the same phylogenetic problems by using different types of 
data and phylogenetic signals.  
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Reconstructing ancestral genomes offers opportunities to study the evolutionary 
mechanisms and trajectories of present species. Studies focused on developing 
computational ancestor reconstruction approaches are facing many difficulties. Present 
computational approaches are suffering from issues of simplistic evolutionary models, 
complex datasets, and complex evolutionary events (Feng et al., 2017; Gao et al., 2015; 
Ma, 2010; Perrin et al., 2015; Sankoff, 2009; Xu & Moret, 2011; L. Zhou et al., 2016). We 
will build an automated pipeline to reconstruct phylogenies and ancestral genomes from 
the whole genome data. First, we will build the phylogenies, and use them as guide trees 
to reconstruct ancestral genomes from the same input data. 
The whole genome level evolutionary studies will improve our understanding of 
evolutionary procedures, gene origins, and gene co-evolutions (Boore, 2006; Sankoff, 
2009). Studies of syntenic blocks in gene order level have several applications in analyzing 
the genome’s structural and functional evolutions (Sankoff, 2009). We will identify the 
syntenic blocks by analyzing the correlations between evolutionary events and these 
functional variations. We can use syntenic blocks as genome markers to detect critical 
evolutionary events, such as functional gene gain and loss. We can also study the genotypes 
and phenotypes of ancestral genomes that have gone extinct. Annotated gene orders within 
shared syntenic blocks can be used to locate the orthologous genes across different species. 
We can use them to trace the gene origins, evolutionary paths, and functional variations in 




2.2.1 Yeast Genome Dataset 
In this study, we reconstructed phylogenies and ancestral genomes for two yeast 
whole genome datasets. Both datasets are available in the Yeast Gene Order Browser 
(YGOB) (http://ygob.ucd.ie) (Byrne & Wolfe, 2005). The first dataset contains the genome 
data of 11 yeast species (Version 3, April 2009), including five post-WGD species under 
four genera (S.cerevisiae, S.uvarum, C.glabrata, N.castelliie, V.polyspora), and six non-
WGD species under four genera (Z.rouxii, K.lactis, E.gossypii, L.kluyveri, 
L.thermotolerans    and L.waltii). This is the same dataset that were used in Gordon’s study 
for reconstructing yeast ancestor (Byrne & Wolfe, 2005; Gordon et al., 2009). The second 
yeast dataset is also available in YGOB (Version 7, August 2012), and contains nine 
additional species compared to the first dataset (Byrne & Wolfe, 2005; Gordon et al., 
2011). Twelve species are post-WGD species under six genera (S.uvarum, S.kudriavzevii, 
S.mikatae, S. cerevisiae, V.polyspora, T.phaffii, T.blattae, N.dairenensis, N.castellii, 
K.naganishii, K.africana, C.glabrata). Eight species are non-WGD species under five  
genera (Z.rouxii,  T.delbrueckii,  K.lactis,  E.gossypii,  E.cymbalariae, L.kluyveri, 
L.thermotolerans, L.waltii). This is also the same data used by Byrne and Wolfe to 
reconstruct the ‘benchmark’ version of ancestral genome in the latest version of YGOB 
(Byrne & Wolfe, 2005; Gordon et al., 2011). 
2.2.2 Binary Encoding Yeast Genome Data 
In this study, we used gene orders to represent gene permutations and directions on 
the chromosomes of yeast genomes. We considered each single gene as a genome marker, 
and used distinct integers to represent the homologous genes across different yeast species. 
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The yeasts homologous genes were defined by the original database YGOB, which was 
based on the BDBH BLASTP (E<1e-5) using L. waltii and S. cerevisiae as reference 
genomes (Byrne & Wolfe, 2005). Each group of homologous genes was represented by a 
specific gene order, no matter how many genes were in this group. We used corresponding 
gene orders to represent the gene permutations and positioning relationships on yeasts 
genomes for all species. In this study, there were total 14,101 gene orders in our high-
resolution genome marker set that used for phylogeny and ancestral reconstructions. The 
sign (+/-) of a gene order indicates gene’s direction or strand. Each gene is labeled by two 
ends, head and tail. The head represents a gene’s 5t end, and the tail represents the 3t end. 
For example, gene 1 can be represented by {1h, 1t}. We used the gene ends and their 
adjacencies to describe the permutations and positional relationships for all genes on the 
chromosome. For instance, if gene 1 and gene 2 were adjacent, or gene −2 was followed 
by gene −1 equivalently, these two genes can form a gene adjacency {1t, 2h}. A gene order 
sequence {1, −2, 3, 4} can be labeled by a set of gene adjacencies: {1t, 2t}, {2h, 3h}, {3t, 
4h}. In this paper, our algorithms further encoded genome content and gene adjacencies 
into binary sequences for each chromosome. For instance, for two genomes with only one 
chromosome, G1= {1, −2, 3, 4}, and G2 = {1, 2, 3, 4, −5}, we binary encode them as shown 
in Table 2.1. 
 




2.2.3 Improve MLWD for Yeasts Phylogenies Reconstruction 
The previous MLWD method was restricted by its fixed evolutionary model and 
the limitations in handling complex evolutionary events, such as deletion, duplication and 
whole genome duplication. In this study, we will consider each single gene as the smallest 
genome marker to process high-resolution genome datasets. First, we will statistically 
analyze the evolutionary rates of different types of events for all species under the 
Saccharomycetaceae family. Next, we will calculate the gene content and gene adjacencies 
transition probabilities according to these genome evolutionary events. 
Next, we will use these transition probabilities to build a constrained evolutionary 
model based on the principle of double-cut-and-join (DCJ) operation (Friedberg, Darling, 
& Yancopoulos, 2008; Yancopoulos, Attie, & Friedberg, 2005). This yeast evolutionary 
model takes all kinds of genome level evolutionary events into account, including 
rearrangements, insertions, deletions, and duplications. Based on the DCJ operation, each 
event will always remove two old adjacencies randomly, and use the new ends to create 
two new adjacencies. However, our yeast evolutionary model also considers that each 
genome has n genes and n + O (C) adjacencies with constrained adjacency variations. There 
are !"#$"
"
% possible ends.  The transition probability to lose an adjacency is estimated by 
"	(($)$*$+)
#$-	(.)
 . The probability to gain a new adjacency is estimated by 	(($)$*$+)
"#/$-	(#)
. n and C 
represent the total number of genes and chromosomes for a specific species. R, D, I and d 
represent the estimated number of rearrangements, duplications, insertion, and deletion 
events for this species based on the evolutionary rates of Saccharomycetaceae family. We 
also applied their corresponding transition probabilities to the ancestral genome 
reconstructions. After encoding the yeast genomes into binary sequences and computing 
the transition probabilities, we fed this information into the phylogeny reconstruction 
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program RAxML with fast bootstrapping (Stamatakis, 2014) to reconstruct the yeast 
phylogeny with overall maximum likelihood. The reconstructed phylogeny and the same 
input genome data will be fed into the next stage PMAG for ancestral reconstruction. The 
bootstrapping support value for each internal node and leaf on the phylogeny is considered 
in three levels: strong support (bootstrap value > 90), medium support (bootstrap value 
between 60 and 90), and weak support (bootstrap value < 60). 
2.2.4 Improve PMAG for Yeast Ancestor Reconstruction 
Most present computational ancestral reconstruction approaches can only process 
simplified real data or simulated datasets with unique genome marker and limited types of 
evolutionary events (Alekseyev & Pevzner, 2009; Feijão & Meidanis, 2009; Hu et al., 
2013; Ma, 2010; Perrin et al., 2015; Xu & Moret, 2011; Zheng & Sankoff, 2011). The 
previous version of our PMAG approach also faced the same problems (Hu et al., 2014, 
2013). In this study, we improved the algorithms of PMAG approach to process all kinds 
of evolutionary events and high-resolution real genome data. Our improved approach was 
based on Bayes theorem and probabilistic frameworks. It used the yeast genome transition 
evolutionary model to compute the gene adjacencies of a specific ancestral genome for 
each edge of the yeast phylogeny. We considered each gene as a basic genome marker and 
reconstructed the ancestral genomes by maximizing the overall conditional probabilities of 
ancestral marker sets along the edges of the phylogenetic tree. 
First, we encoded genome content and gene adjacencies into binary sequences, as 
shown in Table 2.1. The duplicated genes and adjacencies were encoded as additional 
distinct elements and stored into an additional matrix. Furthermore, we computed the 
conditional probabilities for all possible adjacencies across all genomes and assigned the 
probabilities according to their weights. Next, we used the reconstructed yeast phylogeny 
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(from the phylogeny reconstruction step) as the guide tree, and assembled gene adjacencies 
into ancestral genomes for all internal tree nodes with the maximum portability. For each 
ancestral genome reconstruction, we re-rooted the tree and treated the ancestral genome 
that needed to reconstruct as the new root and built the ancestral genome with the global 
maximum probability over all species. We reconstructed gene orders of ancestral nodes by 
using a similar idea from a previous probabilistic reconstruction approach for sequence 
data (Yang, Kumar, & Nei, 1995). We also used the RAxML (Stamatakis, 2014) to estimate 
evolutionary distance "d”. Our method iterated the steps above to compute all the 
probabilities of adjacencies for each internal genome. Once all of these probabilities were 
obtained, we converted this genome adjacencies assembly/reconstruction problem into an 
instance of the Traveling Salesman Problem (TSP), and then used the Chained-Lin-
Kernighan heuristic TSP solver Linkern to solve this problem (Applegate, Bixby, Chvatal, 
& Cook, 2006). The original yeasts input genomes were not well assembled. Many genome 
contigs couldn’t be assembled or mapped back to regular chromosomes. Even though the 
real yeast genome data suffered from these issues, the TSP solver helped us to better 
assemble/reconstruct ancestor genomes by using all available adjacencies information in 
known genomes. We mapped the gene content, gene adjacencies, and duplicated genes 
information with the outputs from TSP solver. Finally, we determined the chromosome 
structures of reconstructed ancestral genomes based on the chromosome structure 
information from its parent and children genomes. We first identified all chromosome 
telomeres for its parent and two children genomes. Next, we introduced the ancestral 
chromosome telomeres with new chromosome telomeres by the following orders: 1, 
telomeres shared by all three genomes (one parent and two children genomes); 2, shared 
by two children genomes; 3, shared by any two genomes; 4 existed in the parent genomes; 
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5 existed in one of children genomes. Finally, when the chromosome number reached the 
number of its two children genome or its parent genome, we output the updated ancestral 
genomes with correct chromosome number and chromosome telomeres. 
2.3 YEAST PHYLOGENIES RECONSTRUCTION 
2.3.1 phylogeny built from 11 yeast species.  
We first used our improved computational approach MLWD (Method 3) to 
construct the phylogeny for the first yeast genomes dataset with 11 species, which are 
available in YGOB (Version 3 April 2009). Five of them are post-WGD species under four 
genera. Six of them are non-WGD species under other four genera. This was the same 
dataset that used in Gordon’s ancestor reconstruction study (Gordon et al., 2009). As shown 
in Figure 2.1, we correctly classified all yeast species into their corresponding genera, and 
also into their corresponding groups, post-WGD and non-WGD. We compared this 
phylogeny with the recent studies and publications. First, we compared with the yeast 
phylogeny from NCBI taxonomy (http://www.ncbi.nlm.nih.gov/taxonomy). Our 
phylogeny was in accord with NCBI taxomony for all 11 species. Our phylogeny also 
matches the phylogeny in Gordon’s ancestral reconstruction study (Gordon et al., 2009). 
Recently, Salichos used a sequence alignment based maximum likelihood approach to 
study the phylogeny of 23 yeast species by concatenation analysis of 1,070 orthologs 
(Salichos & Rokas, 2013). Marcet-Houben and Vakirlis also used similar methods to infer 
the phylogenies of 19 and 34 yeast species from shared orthologs and homologs (Marcet-
Houben & Gabaldón, 2015; Vakirlis et al., 2016). Even though our approach uses gene 
order data and phylogenetic signals from genome level evolutionary events, our phylogeny 
was in accord with each of these three studies on their shared 11 species. These comparison 
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results with the NCBI taxonomy and recent publications demonstrate that our approach can 
reconstruct very accurate phylogeny. 
 
 
Figure 2. 1 Yeasts phylogeny built from all types of evolutionary events from 11 yeast 
species. Each leaf represents a species, and each internal node represents a common 
ancestor (A1 - A9). All internal edges have bootstrapping values of 100 except the branch 
between Lachancea genus and Eremothecium genus, which has a bootstrapping value of 
61. The red line shows the non-WGD species, while the blue line shows the post-WGD 
species. We label A1 - A9 as the reconstructed yeast common ancestors built from the first 
yeast dataset. The ancestor A8 (PMAG09) shows the pre-duplication ancestor PMAG09, 
which is the step before yeasts’ WGD event in evolutionary. 
 
2.3.2 Yeasts phylogeny built from 20 yeast species.  
We continued to construct the phylogeny for the second dataset with 20 species, 
which are available in the latest version of YGOB (version 7 August 2012) (Byrne & 
Wolfe, 2005; Gordon et al., 2011). Twelve of them are post-WGD species under six genera. 
Eight of them are non-WGD species under other five genera. As shown in Figure 2.2, we 
correctly classified these 20-yeast species into their corresponding genera, and also into 
their corresponding groups, post-WGD and non-WGD. This phylogeny also entirely agrees 
with the NCBI taxonomy. Although Salichos, Marcet-Houben, and Vakirlis performed 
similar sequence alignment-based approaches to reconstruct yeast phylogenies by 
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analyzing different gene datasets, their phylogenies still had conflicts between each other 
(Marcet-Houben & Gabaldón, 2015; Salichos & Rokas, 2013; Vakirlis et al., 2016). Our 
phylogeny agrees with Marcet-Houben’s phylongey on each of the shared 18 species, 
except for the placement of K.lactis, which is still at the same evolutionary position in both 
phylogenies. However, it is closer to the Lachancea genus in our phylogeny, while it is 
closer to the Eremothecium genus in Marcet-Houben, Vakirlis, and Salichos’s phylogenies 
(Marcet-Houben & Gabaldón, 2015; Salichos & Rokas, 2013; Vakirlis et al., 2016). We 
could remove this small discrepancy by using the phylogenetic signals only from genome 
rearrangement events. Our phylogeny agrees with Vakirlis’s phylogeny on their shared 20 
species, only has two discrepancies. In our phylogeny, S. bayanus is a sibling of S. 
cerevisiae, which agrees with Marcet-Houben (Marcet-Houben & Gabaldón, 2015). In 
Vakirlis’s phylogeny, S. bayanus is the uncle of S.cerevisiae (Vakirlis et al., 2016), which 
agrees with Salichos (Salichos & Rokas, 2013). For the placement of species N.castellii, 
Marcet-Houben, Vakirlis, and our phylogeny agree with each other, while Salichos’s 
phylogeny does not (Marcet-Houben & Gabaldón, 2015; Salichos & Rokas, 2013; Vakirlis 
et al., 2016). Our phylogeny also agrees with Salichos’s phylogeny on their shared 13 
species except for the differences noted above (Salichos & Rokas, 2013). The differences 
may be caused by the inconsistencies in multiple sequence alignments and inaccuracies in 
gene order annotations. For example, in the yeast genome database YGOB, some genes 
cannot be mapped back to their corresponding chromosomes, which may cause inaccurate 
adjacency information and result in misleading phylogenetic signals (Byrne & Wolfe, 
2005). 
The results above illustrate that our phylogenies are as accurate as those built from 
NCBI taxonomy and sequence alignment based phylogenetic approaches, although we are 
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using the gene order data and phylogenetic signals from genome level evolutionary events. 
Our approach skips the multiple sequence alignment step and avoids the conflicting 
phylogenetic signals from local and biased DNA sequences. We provide an independent 
and alternative way to build the phylogenies for real genome datasets, and eliminate the 
conflicting issues in traditional multiple sequence alignment based approaches. 
 
 
Figure 2. 2 Yeasts phylogeny built from all types of evolutionary events from 20 yeast 
species. Each leaf represents a species, and each internal node represents a common 
ancestor (A1 - A18). All of the internal edges have a bootstrapping value of 100 except the 
branch between Lachancea genus and Eremothecium genus (bootstrapping value of 84) 
and the branch between the S.cerevisiae and S.bayanus (bootstrapping value of 79). The 
red line shows non-WGD species, while the blue line shows post-WGD species. We label 
A1 - A18 as the reconstructed common ancestors built from the second yeast dataset. The 
ancestor A17 (PMAG12) shows the pre-duplication ancestor PMAG12, which is in the 




2.4 YASET ANCESTRAL GENOME RECONSTRUCTIONS 
2.4.1 Yeast Ancestral Genomes Reconstruction From 11 Yeast Species.  
Recently, Wolfe reported that whole genome duplication (WGD) was found in the 
common ancestor of six genera of Saccharomycetaceae family (Wolfe, 2015). Gordon 
applied a parsimony-based approach to reconstruct the common ancestral genome dating 
back to 100 million years ago, right before yeasts’ WGD event (Gordon et al., 2009). 
Gordon used a sequence alignment-based phylogeny as the guide tree, and manually 
reconstructed the gene orders of the ancestral genome from a dataset with 11 yeast species 
(this also refers to the first yeast genome dataset in this study) (Byrne & Wolfe, 2005; 
Gordon et al., 2009). The preliminary version of this manually reconstructed ancestral 
genome was reported as a ‘gold standard’ in Sankoff’s studies (Gordon et al., 2009; Zheng, 
Zhu, Adam, & Sankoff, 2008). In this paper, we use MANUAL09 to represent this version 
of the manually reconstructed yeast ancestor. In 2012, Byrne and Wolfe added nine 
additional yeast species to YGOB. They used the same method and reconstructed the 
‘benchmark’ version ancestral genome, using genome information of 20 yeast species (this 
also refers to the second yeast genome dataset) (Byrne & Wolfe, 2005; Gordon et al., 2011). 
We use MANUAL12 to represent this ‘benchmark’ version ancestral genome. The 
MANUAL12 ancestral genome was built from a dataset that contained more 
comprehensive genome information of yeast species, indicating more accurate ancestral 
reconstructions than the ancestor built from the first dataset (MANUAL09). 
In this section, we first used our improved computational approach PMAG (the 
fourth point of the Methods) to reconstruct the ancestral genomes for the first yeast genome 
dataset. We used the phylogeny that reconstructed from the same input data in Figure 2.1 
as the guide tree. It only took 20 minutes to solve this problem and output all internal and 
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root ancestral genomes for these 11 yeast species. There are nine ancestral genomes 
reconstructed and labeled as A1- A9 in the phylogeny of Figure 2.1. We have listed the 
ancestral genome information in Supplementary dataset 1. Gene numbers of each ancestral 
genome vary between 4,841 and 5,133. Each ancestral genome is represented by a list of 
ancestral genes with their corresponding gene orders that shared across the whole 
Saccharomycetaceae family. Among our reconstructed ancestors, we use PMAG09 (also 
labeled as A8 in Figure 2.1) to represent our pre-WGD ancestor at the same evolutionary 
stage with MANUAL09 and MANUAL12. Our first results comparison was among the 
genome content of PMAG09, MANUAL09, and MANUAL12 ancestors, which contained 
4,856, 4,703, and 4,943 genes, respectively. As Figure 2.3 (a) shows, the genome contents 
of our PMAG09 ancestor are very similar to both MANUAL09 and MANUAL12. Of all 
the genes in PMAG09, 4,645 (95.6%) are shared by MANUAL09, and 4,836 (99.6%) are 
shared by MANUAL12. We also compared all gene adjacencies among these three 
ancestral genomes, which could reflect the absolute differences of gene contents, 
directions, and permutations between any two genomes. Figure 2.3 (a) shows that our 
ancestor PMAG09 shares 4,192 (86.3%) gene adjacencies with MANUAL09, and 4,464 
(91.9%) gene adjacencies with MANUAL12.  
We identified all gene pairs (gene adjacencies) that never split during evolution, 
which were called “non-split adjacencies”. There were 697 “non-split adjacencies” shared 
by the descendant genomes of PMAG09 and MANUAL09, and 269 “non-split 
adjacencies” shared by the descendant genomes of MANUAL12. in our reconstructed 
ancestral genomes, PMAG09 contained 638 (13.1%) “non-split adjacencies”. 
MANUAL09 contained 609 (12.9%) “non-split adjacencies”. MANUAL12 contained 253 
(5.1%) “non-split adjacencies”. After removing the “non-split adjacencies”, PMAG09 still 
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shared 3,554 (84.2%) adjacencies with MANUAL09 and 4,211 (91.4%) adjacencies with 
the “benchmark ancestral genome” MANUAL12. We further identified and compared the 
number of different types of evolutionary events between the automated/manually 
reconstructed ancestors and their shared five present post-WGD descendant genomes. We 
applied a computational method to calculate genome evolutionary events based on the 
principle of double-cut-and-join (DCJ) operation (Friedberg et al., 2008; Yancopoulos et 
al., 2005), which could identify all events that occurred during evolutionary history. Under 
DCJ operation model, if we had identified n evolutionary events between genome A and 
Genome B, the gene order permutations could evolve from genome A to genome B by 
these n events. Figure 2.3 (b) A shows that our ancestor PAMG09 presents the least number 
of genome rearrangement events when compared with MANUAL09 and MANUAL12. 
Figure 2.3 (b) B shows a similar result for gene loss and gain events. Likewise, Figure 2.3 
(b) C shows that our ancestor PMAG09 has the least number of overall evolutionary events 
among these three ancestors. 
These results demonstrate that our ancestor PMAG09 is very similar to both 
manually reconstructed ancestral genomes in genome content and gene adjacencies. 
Although our ancestor PMAG09 is reconstructed from the same data as the old version 
ancestor MANUAL09, it is more similar to the “benchmark” ancestor MANUAL12. 
MANUAL12 is built from the second dataset with more comprehensive genome 
information of nine additional yeast species, which indicates more accurate ancestral 
reconstructions. Moreover, PMAG09 has fewer evolutionary events than both 
MANUAL09 and MANUAL12. Therefore, PMAG09 is more optimal and parsimonious 





Figure 2. 3 Genome content, gene adjacency and evolutionary events comparisons among 
PMAG09, MANUAL09, and MANUAL12 ancestors. Figure (a), Genome content and 
gene adjacency comparisons among PMAG09, MANUAL09, and MANUAL12 ancestors. 
(b), Evolutionary events comparisons among the evolutionary histories of PMAG09, 
MANUAL09, and MANUAL12 ancestors. Figure (b) A, B and C show the total number 
of genome rearrangements events, gene loss and gain events, as well as overall 
evolutionary events between ancestral genomes and their shared five present post-WGD 
descendants. 
 
2.4.2 Yeast Ancestral Genomes Reconstruction from 20 Yeast Species. 
We further reconstructed the ancestral genomes for the second yeast genome 
dataset with 20 species. We used the phylogeny reconstructed from the same input data in 
Figure 2.2 as the guide tree and reconstructed the ancestral genomes within 55 minutes. 
There are 18 ancestral genomes reconstructed and labeled as A1 - A18 in the phylogeny of 
Figure 2.2. Gene numbers of each ancestral genome vary between 4,750 and 5,122. We 
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listed the ancestral genes for each ancestor and analyzed their functions in Supplementary 
Dataset 2. Among the 18 ancestral genomes reconstructed here, we used PMAG12 (also 
labeled as A17 in Figure 2.2) to represent the pre-WGD ancestor at the same evolutionary 
step with MANUAL12. The post-WGD ancestor A17’ had an additional copy of pre-WGD 
ancestor A17. Therefore, it had the same gene orders and genome information as pre-WGD 
ancestor A17. There are 4,813 genes in PMAG12 and 4,943 genes in MANUAL12. As 
Figure 2.4 (a) shows, these two ancestors are extremely similar. PMAG12 shares 4,807 
(99.9%) of its genes and 4,457 (92.6%) of its gene adjacencies with MANUAL12.  
We compared different reconstructions on the proportions of adjacencies that were 
split during evolution. There were 269 “non-split adjacencies” shared by the descendant 
genomes of PMAG12 and MANUAL12. In our reconstructed ancestral genomes, 
PMAG12 contained 258 (5.3%) “non-split adjacencies”. MANUAL12 contained 253 
(5.1%) “non-split adjacencies”. After removing all “non-split adjacencies”, PMAG12 still 
shared 4,199 (92.1%) adjacencies with the “benchmark ancestral genome” MANUAL12. 
We continued to compare the number of different types of evolutionary events between 
ancestors and their 12 descendants. As Figure 2.3 (b) shows, even though PMAG12 and 
MANUAL12 are built from the same dataset, PAMG12 has fewer genome rearrangements, 
fewer gene losses and gains, and fewer total evolutionary events than MANUAL12 in their 
evolutionary history. 
These results also illustrate that our ancestors are very similar to the manually 
reconstructed ancestors in genome content and gene adjacencies. Furthermore, our 
ancestors provide us with more optimal and parsimonious solutions from an evolutionary 
perspective, because our automated approach searches for globally optimal gene 
permutations with maximum likelihood across the entire genome. However, the manual 
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approach only scans a fixed number of genes, and visually compares these gene orders 
(Byrne & Wolfe, 2005; Gordon et al., 2011, 2009). Therefore, the manual ancestral 
genomes might be restricted in a local view of gene adjacency and content, and reach a 
solution with a set of local optimums. Moreover, as we expected, Figure 2.4 (a) shows that 
PMAG12 is more similar to the latest ‘benchmark’ ancestor MANUAL12 when compared 
with our PMAG09 built from the first dataset in Figure 2.4 (a). 
 
Figure 2. 4 Genome content, gene adjacency, and evolutionary events comparisons 
between PMAG12 and MANUAL12 ancestors. (a), Genome content and gene adjacency 
comparisons between PMAG12 and MANUAL12 ancestors. (b), Evolutionary events 
comparisons between the evolutionary histories of PMAG12 and MANUAL12 ancestors. 
Figure (b) A, B and C show the total number of genome rearrangements events, gene loss 






2.5 ANCESTRAL GENOME RECONSTRUCTION ON SIMULATED DATA
To explore the performance of these ancestral reconstruction approaches, we select 
four most famous and powerful approaches from both distance/event-based and 
homology/adjacency-based categories. We analyze and compare their performance on 
simulated datasets and evaluate their outputs. For the distance/event-based approaches, we 
select MGRA2 and GASTS. MGRA2 is the only distance/event-based approach that could 
deal with all kinds of evolutionary events (Avdeyev et al., 2016). GASTS is famous for its 
speed and accuracy for small-scale datasets, but it could only handle the problems with 
equal genome content (Xu & Moret, 2011). For the homology/adjacency-based 
approaches, we select our method PMAG and Gapped Adjacency (Gagnon et al., 2012).   
In order to compare the performances in unequal content genome datasets with more 
complicated genome evolutionary events, we set up evolutionary events between any two 
generations with 80% inversions, 10% translocations, 5% insertions and 5% deletions. The 
settings for the evolutionary rates and genome sizes are the same.  
Figure 2.2 presents the results analyses and comparisons for these four approaches. 
For the distance/event-based approaches, GASTS could not handle these complicated 
evolutionary events. MGRA2 was reported being capable of handling this kind of problem 
(reference) but was not able to give any output after running for 48 hours for any of these 
datasets. Only the homology/adjacency-based approaches could solve these problems and 
reconstruct the ancestral genomes. As it shown in Figure 2.5 (A), PMAG preserve very 
high gene adjacency accuracy (almost 1.0) for all four datasets with different genome size, 
while the accuracy of Gapped Adjacency is always about 10% lower (around 0.9) than 
PMAG. Both PMAG and Gapped Adjacency could reconstruct the genome contents with 
very high accuracy. PMAG preserves a higher accuracy (almost 1) than Gapped Adjacency 
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(around 0.95) in the genome content reconstruction. Gapped Adjacency requires less 
running time than PMAG. Figure 2.5 (B) shows, when the evolutionary rate reaches 1, 
PMAG could still keep a high accuracy (around 0.95), while Gapped Adjacency could only 
reach the accuracy of 0.8. In the genome content and running time comparison, they have 
the similar result with Figure 2.5 (A). Figure 2.5 (C) shows the performance of these 
approaches under high evolutionary rate r=2. In this experiment, PMAG can still grantee a 
sound gene adjacency accuracy of 0.8 for all four genome datasets. However, the Gapped 
Adjacency can only reach the accuracy of 0.6.  PMAG also maintains higher accuracy (> 
0.95) than Gapped Adjacency (around 0.9) in the genome content reconstruction. 
Compared with the three experiments above, PMAG outperforms Gapped 
Adjacency in reconstructing the ancestral genome adjacency and genome content. PMAG 
preserves consistently better performance than the Gapped Adjacency in all cases. As the 
evolutionary rate getting higher, the accuracy gets lower, but PMAG could still keep a high 
accuracy even the evolutionary rate is high. Both PMAG and Gapped Adjacency can 
maintain very high accuracy in reconstructing the genome content. Both of them only 
require hundreds of seconds to get the solutions for the small-scale or large-scale dataset. 
The genome size of the testing dataset also has little influence on the performance of 
accuracy for gene adjacency and genome content, but it did affect the running time. Gapped 
Adjacency requires less running time than the PMAG in all experiments. MGRA2 cannot 




Figure 2. 5  Results analyses and comparisons of different approaches on simulated genome 
datasets. The legend of MGRA2 is missing in this figure, because it cannot give any output 
after running for 48 hours. The legend of GASTS is missing in this figure, because it cannot 
handle these datasets. 
 
2.6 SYNTENIC BLOCK AND THEIR GENE ONTOLOGY ANALYSIS 
2.6.1 Evolutionary and Syntenic Block Comparisons among Reconstructed Ancestors 
Comparisons analyses of syntenic blocks between genomes are powerful 
approaches to study genomic evolution, gene origin, and gene co-evolution (Bhutkar et al., 
2008; Sankoff, 2009). In this study, we followed the above rules to define the syntenic 
blocks, which was the genomic regions that contain two or more genes, maintaining the 
same gene order and orientation (Ghiurcuta & Moret, 2014). We ran whole genome 
comparisons among our automated reconstructed ancestors and manually reconstructed 
ancestors. We identified all syntenic blocks and analyzed their gene functions in 
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Supplementary Dataset 3. As Table 2.2 shows, PMAG09 shares 337 syntenic blocks with 
MANUAL09, which contains 4553 (93.7%) syntenic genes. PMAG09 shares 256 syntenic 
blocks with MANUAL12, which contains 4753 (94.2%) syntenic genes. Although both 
PMAG09 and MANUAL09 are reconstructed from the same dataset, PMAG09 is more 
similar to MANUAL12 in genome contents and chromosome sub-structures (shares more 
syntenic genes, less syntenic blocks, and longer syntenic block lengths). Table 2.2 also 
shows that PMAG12 shares 233 syntenic blocks with MANUAL12, which contains 4733 
(93.7%) syntenic genes. PMAG12 has the highest similarity with MANUAL12 in genome 
contents and sub-structures when compared with MANUAL09 and PMAG09. We also 
draw the chromosome dot plots between our ancestors and the "benchmark" ancestor 
MANUAL12, which could illustrate the level of colinearity between them. As the Figure 
2.6 (a) and (b) shown, our reconstructed ancestral genome PMAG09 and PMAG12 have 
good chromosome colinearity with the “benchmark” ancestral genome MANUAL12, 
which illustrated that they shared many same chromosome sub-structures. In addition, 
Figure 2.6 (b) also illustrates that our PMAG12 ancestor has better chromosome colinearity 
with the "benchmark" ancestral genome MANUAL12 when compared with PMAG09. 
As we expected, our ancestor PMAG09 and PMAG12 was more consistent with 
the latest ’benchmark’ ancestor MANUAL12 in genome contents and structures than 
ancestor MANUAL09, which was built from the first dataset. Furthermore, our PMAG12 
ancestor was more consistent with MANUAL12 than our PMAG09 ancestor, since the 
reconstruction of PMAG12 uses additional information. The results above are also 
consistent with the results that we obtained in the ancestral genome dot plots in Figure 2.6, 
as well as the results in the ancestor genome contents and gene adjacencies comparisons in 








Figure 2. 6 Chromosome dot plots between our ancestors and the "benchmark" ancestor 
MANUAL12. The eight y-axes of eight sub-figures showed the eight chromosomes of 
MANUAL12. The x-axes of each sub-figures represented all eight chromosomes of our 
ancestors. 
 
2.6.2 Gene Function and Ontology Analyses of Syntenic Blocks 
Next, we continued to run whole genome comparisons between all 
automated/manually reconstructed ancestral genomes and their five present post-WGD 
descendants to identify their shared conserved syntenic blocks. Table 2.3 shows that both 
PMAG09 and PMAG12 share more syntenic genes with the present yeast species than 
MANUAL09 and MANUAL12 do. They also preserve less syntenic blocks and longer 
average syntenic block lengths with present yeast species. These results demonstrate that 
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our ancestors PMAG09 and PMAG12 share more genome contents and sub-structures with 
the present yeast species when compared with manually reconstructed ancestors. These 
results also illustrate that our automated reconstructed ancestors are more optimal and 
parsimonious genomes than manually reconstructed ancestors from an evolutionary 
perspective, which also agrees with our previous results in Figure 2.3 (b) and Figure 2.4 
(b). Furthermore, we annotated the genes and analyzed their functions for each syntenic 
blocks among automated/manually reconstructed ancestors and present yeast species. This 
information is critical to locate conserved co-evolution genes and functional gene groups 
that exist in both ancestral and present species. It can be used to discover the correlations 
between genome level structural and functional variations in yeasts’ evolutionary history.  
For example, there are only a total of six genes in overall 7,165 genes associated with the 
nucleotide salvage process in S.cerevisiae. The syntenic block No.2 shared by PMAG12 
contains two of them in total eight genes (YDR399W and YDR400W), which has the p-
value of 0.002 in the gene ontology analysis. These results indicate that YDR399W and 
YDR400W are conserved co-evolution genes to maintain their structural and functional 
relationships in evolutionary processes. 
Our approach uses a new evolutionary model that can process the real whole 
genome data, non-identical content data, and all types of complex evolutionary events. This 
model is based on the principle of double-cut-and-join (DCJ) operations and incorporates 
the evolutionary rates of the Saccharomycetaceae family. It can be extended to other 
multiple chromosome species after we encode all existing genes into gene orders and 









Initially, studies of yeast phylogenies were based on morphological phenotypes and 
characters such as sexual states, germinations, and fermentations (Kurtzman et al., 2011). 
Currently, widely accepted yeasts phylogenetic approaches are based on multiple sequence 
alignment. However, they still have limitations and often have conflicting results with each 
other (Hedtke et al., 2006; Marcet-Houben & Gabaldón, 2015; Salichos & Rokas, 2013; 
Vakirlis et al., 2016). In this study, we reconstructed the phylogenies for two high-
resolution yeasts genome datasets by using the phylogenetic signals from genome level 
evolutionary events. The comparisons with the NCBI taxonomy and recent publications 
demonstrated that our approach could also reconstruct very accurate and robust 
phylogenies. We provide a new and alternative method to resolve the same phylogenetic 
problems but using different types of data and phylogenetic signals. Our approach 
considers each gene as a single marker and uses 14,101 total markers. Therefore, it will not 
miss the phylogenetic signals from small-scale evolutionary events. It skips the multiple 
sequence alignment step and avoids conflicting phylogenetic signals from distinct 
molecular sequences in traditional phylogenetic approaches. Therefore, our approach can 
eliminate the conflicting issues that exist in current multiple sequence alignment-based 
phylogenetic approaches. Current whole genome level phylogenetic studies on real data 
are limited in simplified identical content genomes(Luo et al., 2012) and mitochondrial 
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datasets(Figueroa & Baco, 2015; Weigert et al., 2016). However, our approach uses a new 
evolutionary model that can process the real whole genome data, non-identical content 
data, and all types of complex evolutionary events. This model is based on the principle of 
double-cut-and-join (DCJ) operations and incorporates the evolutionary rates of the 
Saccharomycetaceae family. It can be extended to other multiple chromosome species after 
encoding all existing genes into gene orders and marking out all possible homologous 
genes that shared by more than one genome. 
Reconstructing ancestral genomes offers opportunities to study the evolutionary 
mechanisms and trajectories of present species. Studies that focused on developing 
computational ancestor reconstruction approaches face many difficulties. Present 
computational approaches suffer from issues of simplistic evolutionary models, complex 
datasets, and complex evolutionary events (Feng et al., 2017; Gao et al., 2015; Ma, 2010; 
Perrin et al., 2015; Sankoff, 2009; Xu & Moret, 2011; L. Zhou et al., 2016). Recent studies 
of Vakirlis’ et al. have made great achievements in computational ancestral reconstruction 
approaches. The newly sequenced ten yeast species in the Lachancea genus and used 
software AnChro to reconstruct the ancestral genomes on the Lachancea genus level 
(Vakirlis et al., 2016). They used SynChro to identify conserved syntenic blocks based on 
the DNA sequence information and additional parameters (Drillon, Carbone, & Fischer, 
2014). They used ReChro to identify cycles of breakpoints for each pairwise combination 
of genomes (Drillon, Carbone, & Fischer, 2011). They provided a granular view of genome 
evolution within an entire eukaryotic genus (Vakirlis et al., 2016). In this study, we built 
an automated pipeline to reconstruct phylogenies and ancestral genomes from whole 
genome data. First, we built the phylogenies and then used them as guide trees to 
reconstruct ancestral genomes from the same input data. Experiments on simulated datasets 
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illustrate that our approach achieves better performances than another current, automated 
ancestor reconstruction approaches. Ancestor reconstructions on two real yeast genome 
datasets show that our ancestors are very similar to the manually reconstructed 
"benchmark" ancestral genomes in genome contents, gene adjacencies. They also shared 
many chromosome sub-structures with each other. Our maximum likelihood-based 
ancestral reconstruction approach treats the entire genome as a single stage out of billions 
of possible genome permutation stages and searches for the global optimal genome 
permutations. We considered each gene as a basic marker and reconstructed ancestral 
genomes by maximizing the overall conditional probabilities of the ancestral marker sets 
along the edges of the phylogenetic tree. We used a TSP (Traveling Salesman Problem) 
solver to connect ancestral gene adjacencies into genomes with maximum probability, 
which could successfully assemble ancestral genes into complete chromosomes with low 
error rates. 
Whole genome level evolutionary studies improve our understanding of 
evolutionary procedures, gene origins, and gene co-evolution (Boore, 2006; Sankoff, 
2009). Studies of syntenic blocks in the gene order level have several applications in 
analyzing the genome’s structural and functional evolutions (Sankoff, 2009). In this study, 
we identified the syntenic blocks, which were shared by our ancestors and manually 
reconstructed ancestors. Analysis results of the syntenic blocks can obtain the same 
conclusions with the comparison results from genome content and adjacencies discussed 
in Figure 2.3 and Figure 2.4. We also did functional analyses of these conserved syntenic 
genes and blocks. The information from these ancestral syntenic blocks is more reliable 
and credible since it is confirmed by two different ancestral reconstruction approaches. We 
also identified the conserved syntenic blocks between the ancestral genomes and their 
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shared five present post-WGD descendants. These results can be used to locate the syntenic 
genes and blocks, which were inherited from the same ancestor to maintain their functional 
relationship during evolutionary processes. Genome-level evolutionary events may also 
break old syntenic blocks, and bring new blocks with new genetic relationships, which can 
result in structural and functional variation. By analyzing the correlations between 
evolutionary events and these functional variations, we can use syntenic blocks as genome 
markers to detect critical evolutionary events, such as functional gene gain and loss. We 
can further study the genotypes and phenotypes of ancestral genomes that have gone 
extinct. Annotated gene orders within shared syntenic blocks can be used to locate the 
orthologous genes across different species. We can use them to trace the gene origins, 








CHAPTER 3  
CKD DIAGNOSES MODEL CONSTRUCTION AND FEATURE 
SELECTION USING MACHINE LEARNING AND METABOLITES 
DATA 
3.1 MOTIVATIONS  
Chronic kidney diseases (CKD) are progressive and heterogeneous disorders 
affecting kidney structures and functions. Now they become major challenges to public 
health. Early stage detection, special stage managements and corresponding treatments can 
significantly prevent and delay the progressions of CKDs. Current clinical CKD stage 
diagnoses methods are based on the level of glomerular filtration rate (GFR). However, 
there are inaccurate and contradictory issues among different GFR estimating equations 
and approaches. 
In this study, we will provide a novel and independent way to diagnose the CKD 
stages without measuring the GFR, which could overcome the inaccurate and contradictory 
issues that caused by present various GFR estimating approaches and equations. We will 
use three supervised learning algorithms to build CKD stage diagnosis/classification 
models to diagnose the six stages of CKD (five CKD stages and non-CKD). We will 
analyze a large volume of metabolite datasets obtained from positive ion mass 
 
 39 
spectrometry of clinical blood samples, which is collected by Vanderbilt University 
Medical Center. We first build three CKD stage diagnosis/classification models based on 
the original 16382 metabolite features. Then we will develop a feature selection algorithm 
to identify the most critical and informative and critical metabolite features related to the 
metabolic pathways and developments of CKD stages. We will further use the selected 
metabolite features to construct improved and simplified CKD stage 
diagnosis/classification models, which only requires the selected features to determine the 
CKD stages in practice. 
Furthermore, we will apply the unsupervised learning algorithms to validate that 
the selected metabolite features are the most critical factors correlated with the symptoms 
and progressive perturbations of CKD stages. Finally, we will study the correlations among 
selected metabolite features and the developments of CKD stages. The selected metabolite 
features could provide insights into CKD early stage diagnosis, pathophysiological 
mechanisms, CKD treatments, and medicine development. 
3.2 METHODOLOGY 
3.2.1 Data 
The dataset used in CKD screening and stage diganoses study contained 703 
patients’ blood metabolic levels of 16382 metabolites identified by positive ion mass 
spectrometry, which was collected by Vanderbilt University Medical Center. There were 
703 patients in the dataset used in this study, including 587 CKD patients in five different 
CKD stages and 116 non-CKD patients. 120 patients were in CKD stage 1; 104 patients 
were in CKD stage 2; 110 patients were in CKD stage 3; 119 patients were in CKD stage 
4; and 134 patients were in CKD stage 5 (the final stage). Each blood sample was analyzed 
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by positive ion mass spectrometry and therefore identified total 16382 metabolites, which 
were also referred to the 16382 features in the original metabolite dataset. We further 
normalized all patients’ metabolic levels for each metabolite feature into the interval [0,1], 
which was performed by the MinMaxScaler algorithm from Scikit Learn package 
(Pedregosa et al., 2011) and Python. 
3.2.2 Feature Selection  
The feature selection algorithm that used CKD screening and stage diagnosis study 
was implemented by Python and Scikit Learn package (Pedregosa et al., 2011). This 
selection method was based on the ideas of univariate feature selection algorithms, 
recursively elimination algorithms and embedded supervised learning classifiers. First of 
all, we normalized all patients’ metabolic levels for each metabolite into the interval [0,1]. 
Then, we applied the univariate feature selection filter algorithm SelectKBest to select the 
most important n features with the highest scores. This was based on the Chi-squared 
statistics. Next, given the 10-fold cross-validation C-Support Vector Classification as the 
external estimator, we recursively assigned weights to each available metabolite feature 
and eliminated the feature with the least weight from the current feature set. This procedure 
was recursively repeated on the same feature set until the feature number was eventually 
reached the threshold. Then we recursively pruned features from the current n SelectKBest 
features and obtained a subset A with a feature. Meanwhile, we used the embedded 
Random Forest classifier as a black box to find the most important b feature subset B from 
the current n features that selected from SelectKBest. At last, we obtained selected features 
that were in the intersections of subsets A and B. We parallelly ran the above steps for t 
times and got the unions of the intersections of subsets A and B obtained in the last step. 
Finally, we selected 69 metabolite features from the original 16382 features. 
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3.2.3 Supervised Learning Algorithms  
All three supervised learning algorithms used throughout the CKD screening and 
stage diagnosis study and Down Syndrome screening study were implemented by Python 
and Scikit Learn package (Pedregosa et al., 2011). The Random Forest algorithm used in 
this study was set to a forest with total ten trees. It used the Gini impurity as the supported 
criteria. The maximum number of features was set to the total number of features in the 
dataset. The maximum depth of the tree was set to “until all leaves are pure or all leaves 
contain less than two nodes”. The Support Vector Machine algorithm was implemented by 
the multi-class classification C-Support Vector Classification with the linear kernel and 
“one-against-one” scheme. The penalty parameter C of the error term was set to 1.0. 
The degree of the polynomial kernel function was set to 3. The coef 0 was set to 0. The 
Decision Tree algorithm used in this study was the Classification and Regression Tree, 
which was similar to C4.5 Decision Tree algorithm. This algorithm also used Gini impurity 
to measure the quality of a split feature. The maximum number of features was set to the 
total number of features in the dataset. There was no limit to the depth of this Decision 
Tree. The threshold for early stopping in tree growth was set to 1e-7. Before constructing 
the CKD stage diagnosis/classification models, we normalized all patients’ metabolic 
levels for each metabolite features into interval [0,1]. Then we randomly selected the first 
603 instances as a training set and used the rest 100 instances as testing sets. We also ran a 
10-folds cross-validation for each classifier to provide a systematic evaluation of the 
constructed CKD stage diagnosis/classification models. 
3.2.4 Unsupervised Learning Algorithms  
Principal component analysis (PCA) was implemented by Python and Scikit Learn 
package (Pedregosa et al., 2011). It utilized a linear dimensionality reduction by Singular 
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Value Decomposition and projected all patients’ data into three dimensions. The 
hierarchical/agglomerative clustering for all patients was implemented by SciPy package, 
which utilized the Ward variance minimization algorithm to compute the distances among 
all patients. The hierarchical clustering heatmap, CKD stage correlation heatmap were both 
implemented by Python, pandas, and Seaborn packages. The correlation study among the 
selected features was computed by Kendall Tau correlation coefficient, which was 
performed by Python, pandas, and Seaborn packages (McKinney, 2012; Pedregosa et al., 
2011; Waskom et al., 2016). 
3.3 CKD STAGE DIAGNOSIS/CLASSIFICATION MODELS BUILT ON ALL 
METABOLITE FEATURES 
In this section, we applied Random Forest, SVM and Decision Tree three 
supervised learning algorithms to build CKD stage diagnosis/classification models. First 
of all, we normalized patients’ metabolic levels for each metabolite feature into the interval 
[0,1]. Next, we randomly selected 603 patients data as the training set, and used the rest 
100 patients for testing. Then we constructed three multivariate CKD stage 
diagnosis/classification models based on the analyses of the metabolic levels of 16382 
metabolite features that obtained by blood positive mass spectrometry. To provide 
systematic evaluations of these diagnosis/classification models, we ran ten parallel 
experiments with randomized datasets for each constructed model and computed their 
average performance metrics. Meanwhile, we also performed 10-fold cross-validation on 
the entire dataset to test their robustness and reliabilities of the constructed models. 
The data analyses, programing, and methods configurations were implemented by Python 
and Scikit Learn packages (Pedregosa et al., 2011). As Table 3.1 shown, all three 
constructed models achieved very good performances in the CKD stage 
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prediction/classification and in the 10–fold cross-validations, which all reached over 95% 
accuracies. The model built from Random Forest achieved the best performance, which 
had an accuracy of 95.6% in the CKD stage prediction/classification and an accuracy of 
96% in the 10-fold cross-validation. The SVM model had the worst performance with an 
accuracy of 95.4% in the CKD stage prediction/classification and 96% in the 10-fold cross-
validation. The Decision Tree model performed in the middle of the other two models, 
which achieved an accuracy of 95.5% in the CKD stage prediction/classification and 95% 
in the 10-fold cross-validation. Table 3.1 also showed that all CKD stage 
diagnosis/classifications models had very high average precisions, recalls and F-scores. 
Figure 3.1 (A) showed the confusion matrices of the constructed CKD stage 
classification/prediction models in predicting the CKD stages of 100 patients. All three 
models achieved high accuracies with only four mispredictions for each. No patient in non-
CKD or early stage of CKD was mispredicted into wrong CKD stages. In conclusion, we 
provided a novel and independent way to diagnose the CKD stages based on the analyses 
of blood metabolic levels of 16382 metabolites features, which didn’t require the 
estimation of GFR and overcame the contradictory issues caused by different GFR 
estimation approaches. 
 







Figure 3. 1 Confusion matrices of the CKD stage classification/prediction models built 
from the same training and testing data set. 
3.4 CKD STAGE DIAGNOSIS/CLASSIFICATION MODELS BUILT ON SELECTED 
METABOLITE FEATURES 
In last section, we constructed three CKD stage diagnosis/classification models 
based on all 16382 metabolite features, which achieved very good performances. 
However, it’s impractical to have all 16382 metabolites features measured properly for 
each clinical test due to the cost of data collections, efficiency and timeliness, and errors 
of data observation and measurements. Therefore, the brief, fast, and robust models were 
required to perform reliable and fast CKD stage diagnoses for patients with potential risks. 
In this section, we will develop a feature selection algorithm to identify the most critical 
and informative metabolite features from the original 16382 metabolite features. The goal 
was to identify the critical biomarkers and metabolic pathways components that were 
related to symptoms and developments of different CKD stages. Furthermore, we used the 
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selected metabolite features to construct improved and simplified CKD stage 
diagnosis/classification models.  
Our selection method was inspired by the ideas of univariate feature selection 
algorithms, recursively elimination algorithms, and embedded supervised learning 
classifiers. We first used the univariate feature selection filter algorithm SelectKBest to 
select the most important n features, which was based on the Chi-squared statistics. 
Next, given the external SVM estimator of C-Support Vector Classification, we recursively 
pruned features with the least assigned weight from current n features selected from 
SelectKBest into a feature subset A, which was based on the evaluation metrics of 10-fold 
cross-validation. Meanwhile, we used the embedded Random Forest classifier as a black 
box to find the most significant feature subset B with from current n features selected from 
SelectKBest. Finally, we obtained the union of the selected features from the parallel 
intersections of subsets A and B, and obtained 69 metabolite features. We further utilized 
these selected 69 metabolite features subset to construct the improved and simplified CKD 
stage diagnosis/classification models. The details of our feature selection algorithm and 
implementation of CKD stage diagnosis/classification models were available in the 
Methods section. 
As Table 3.2 shown, although the new CKD stages diagnosis/classification models 
were built from the selected metabolites features and were significantly simplified, they all 
achieved improvements in all evaluation metrics (accuracy, precision, recall, F-score and 
10-fold cross validation) when compared with the models that built with all 16382 features 
in last section. Random Forest maintained the best performance over all three models. Its 
accuracy was increased from 95.6% to 98.6%. The SVM model still had the worst 
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performance but with some improvement (accuracy increased from 95.4% to 97.2%). The 
accuracy of Decision Tree model was increased from 95.5% to 97.3%. 
Figure 3.1 also showed the confusion matrices of the improved CKD stage 
classification/prediction models built from the same training and testing data set that used 
in the last section. There were clear improvements in the CKD stage 
prediction/classification compared with the model we built before. All of them obtain 
higher accuracies in diagnoses the CKD stages of 100 patients. Only three patients were 
mispredicted by the models built from Random Forest and Decision Tree. Only two 
patients were mispredicted by the SVM models. Also, no patient in non-CKD or early 
stages (stage 1 and stage 2) of CKD was mis-predicted into wrong CKD stages in all three 
models. Currently, a few studies had demonstrated that the levels of a few metabolites were 
associated with the CKD pathophysiologic processes and affected the developments of 
CKD stages (McMahon et al., 2017; Shah et al., 2013; Weiss & Kim, 2012). However, 
previous studies cannot determine the CKD stages only by the analyses of a few 
metabolites.  
 






3.5 VALIDATION OF SELECTED METABOLITES FEATURE SUBSET 
Previous studies already revealed that the metabolic levels were associated with the 
pathophysiologic processes and developments of CKD stages (Shah et al., 2013; Weiss & 
Kim, 2012). In this part, we applied unsupervised learning algorithms to further validate 
the results of selected metabolites features. We demonstrated that the selected metabolite 
features were the most correlated and informative bio-markers and components, which was 
associated with the CKD pathogenesis and progressions. First of all, we removed the stage 
labels and performed the Principal component analysis (PCA) for all 703 patients based on 
both 16382 metabolite features and selected features. Then we projected all patients’ data 
into three dimensions. After that, we marked the true CKD stages with six different colors 
and showed stages distributions of all patients in 3D spaces. As Figure 3.2(A) and Figure 
3.2(B) showed, PCA results based on the selected metabolite features set could better 
discriminate the CKD stages compared with the PCA results from all metabolite feature 
set.  
 
In addition, we applied hierarchical/agglomerative clustering to cluster all patients 
based on all 16382 metabolite features and the selected features. First, we removed the 
class labels for all patients. Afterward, we used the Ward variance minimization algorithm 
to compute the distances among all patients and then constructed hierarchical trees. We 
further plotted the cluster heat maps to visualize the levels, patients’ hierarchical trees, 
features’ hierarchical trees, and patients’ true CKD stage labels for two feature sets. As 
Figure 2(C) and 2(D) shown, the selected metabolites features could better cluster the CKD 
patients into six stages when compared with the results from all metabolites features. In 
Figure 3.2 (D), patients within the same stages could be better clustered into the same 
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hierarchical sub-trees when compared with Figure 3.2 (C). Patients in Figure 3.2 (D) could 
also better match their true CKD stage labels (shown six red color level) when compared 
with Figure 3.2 (C). In addition, in Figure 3.2 (C), there were lots of features fluctuated in 
similar patterns according to the CKD stage changes. These features were clustered into 
hierarchical sub-trees and showed as dense clusters in green color. However, in Figure 3.2 
(D), the levels of the metabolite features were not clustered into dense clusters but were 
fluctuated with different patterns according to the CKD stages changes. These results 
demonstrated that there were many redundant features and redundant information in the 
original feature set. Our feature selection method could remove these redundant features 
and kept the most critical and stage correlated features. The results above demonstrated 
that the selected metabolites were correlated and fluctuated with the developments of CKD 
stages, which were also the best indicators to discriminate the CKD stages effectively. 
These results also explained why we could construct better CKD stages diagnosis models 
with the selected metabolite features. The selected metabolite features were the most 
critical and informative metabolic components that correlated with the metabolic level 
pathognomonic symptoms of CKD stages. Their variations could reflect the progressive 





Figure 3. 2 Analyses of selected metabolites subset based on unsupervised learning 
algorithms. Figure A and B are the PCA dimension reductions for all 16382 metabolite 
features dataset and selected 69 metabolite features dataset. Figure C and Figure D are the 
hierarchical/agglomerative clustering heatmaps based on all 16382 metabolite features and 
selected 69 metabolite features. The red bar (six color level) represents the original CKD 
stage of each patient. The green color represents the levels for each feature. The 
hierarchical tree on the left represents patient’s sample hierarchical/agglomerative 





3.6 CORRELATION ANALYSES AMONG METABOLITES FEATURES AND CKD 
STAGES. 
In this section, we studied the correlations among levels of selected metabolite 
features and CKD stage developments. As Figure 3.3 (A) showed, the levels of these 
selected metabolic features maintained similar levels within the same CKD stage. On the 
other hand, the levels had changed significantly among different CKD stages. For example, 
the levels of metabolites feature 6, 7 and 20 had significantly increased with the 
aggravation of CKD stages. However, the levels of metabolites feature 58 of 65,66 had 
significantly decreased with the aggravation of CKD stages. The levels of metabolites 
feature 17, 22 and 25 did not show any increase or decrease but showed distinct levels in 
different CKD stages. Levels of these selected metabolites feature changed regularly with 
the development of CKD stages. Therefore, levels of these selected features can affect, or 
be affected by progressive CKD developments and related abnormalities. The variances of 
these selected metabolite features were essential information for the CKD stage 
pathological studies and related medicine developments. In addition, Figure 3.3 (B) 
showed the correlation coefficients heatmap among the selected metabolite features. The 
light color indicated weak correlations, which could be as low as 0. The dark color 
indicated strong correlations, which was up to 1. Most features showed low correlation 
levels, which had correlation coefficients between -0.4 and 0.4. The max correlation 
between any two features was 1, which was the correlation with itself (showed in the 
diagonal line). Most selected features were irrelevant to each other, indicating that there 
was no redundant feature or information in the selected metabolite feature set. This result 
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was also consistent with the result in the heat map of Figure 3.2(D) in the section above. 
 
Figure 3. 3 Correlation analyses among metabolites features and CKD stages. Figure A 
shows the correlations between CKD stages and the metabolic level of selected metabolite 
features. Figure B shows the correlation levels among the selected metabolite features. 
 
3.7 DISCUSSION 
Early CKD stage and Non-CKD detection are critical to the prognosis and 
intervention of CKDs. Specific treatments and management for different CKD stages can 
significantly prevent and delay the disease promotions and progressions (Jha et al., 2013; 
Levey et al., 2003; Morton et al., 2010). Renal failure could also be reversed if the CKD 
were detected and treated in early stage (Levey et al., 2003; Morton et al., 2010). However, 
diagnosis and management of CKD were usually made when symptoms became severe or 
after accidentally findings from clinical testing for other diseases or symptoms (Webster et 
al., 2017). Currently, CKD stages in clinical diagnoses are mainly determined by the levels 
of GFR, with consideration of only a few bio-factors (Levey et al., 2002). However, it is 
not robust or reliable enough to determine the CKD stage or make accurate decisions only 
based on the level of GFR and a few additional factors. That is also why the currents GFR 
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based CKD stages diagnose methods have many inaccurate and contradictory issues due 
to various GFR equations and approaches (Bevc et al., 2017; Canales et al., 2017; Levey 
et al., 2003, 2009). In this study, we first used supervised learning algorithms to construct 
high-performance CKD stage diagnosis/classification models based on the blood metabolic 
level of 16382 features, which overcame the contradictory issues caused by different GFR 
estimation approaches. However, in practice, it’s also impractical to have all 16382 features 
measured for each clinical test due to the cost of data collections, efficiency, and timeliness. 
Therefore, we further constructed the improved and simplified CKD stages 
diagnosis/classification models by comprehensively considering and analyzing the data 
with selected metabolite features, which significantly reduced the cost and time in clinical 
CKD screening and stage diagnoses. Improved CKD stage diagnosis/classification models 
could diagnose the CKD stages through a regular blood test before special scans discovered 
it. They only required the measurements of 69 metabolite features from blood samples, 
which significantly reduced the cost, and at the same time, improved the efficiency of CKD 
screening and stage diagnoses. On the other hand, previous machine learning based CKD 
diagnostic studies focused on distinguishing CKD and Non-CKD patients. Our CKD stages 
diagnosis/classification models could diagnose CKDs into six stages (five CKD stages and 
non-CKD) with very high accuracies and low false-positive rate. Also, they had no error 
in determining the non-CKD or early CKD stages (stage 1 and stage 2), which could be 
further used for CKD screening. We provided a novel, brief, and feasible machine learning 
based approach to screen and diagnose CKDs without measuring the GFR.  
 
Previous studies revealed that the metabolic levels were associated with CKD 
pathophysiologic processes and were contributed to the progressions of CKDs (McMahon 
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et al., 2017; Shah et al., 2013; Weiss & Kim, 2012). For example, abnormalities of mineral 
metabolites would result in higher risk of end-stage of CKD in patients with hypertensive 
nephrosclerosis (Scialla et al., 2013). In this study, we developed a feature selection 
algorithm to identify the most critical and correlated metabolite features that were involved 
in the progressive perturbations of CKD stage and related biological pathway processes. 
Our feature selection method selected the most critical and correlated 69 features from the 
original 16382 metabolites features. These selected features not only helped us construct 
improved and simplified CKD diagnosis/classification models but also revealed the effects 
of these selected metabolites features in the developments of CKD stages and their 
pathophysiologic mechanisms. Unsupervised PCA analysis and 
hierarchical/agglomerative clustering analysis demonstrated that the selected metabolite 
features could better distinguish the CKD stages than the original 16382 features do. 
Features correlation studies also showed that most selected features had a regular increase 
or decrease variations according to the developments of CKD stages. Some of the selected 
metabolite features didn’t show any corresponding increase or decrease but did show 
distinct levels in different CKD stages. Therefore, variances of selected metabolite levels 
could affect or could be affected by the progressive developments of CKD. Furthermore, 
we studied the correlations among the selected metabolites features and found that there 
were very few correlations among selected metabolite features, which indicated there was 
no redundant feature or information in the selected features. Therefore, these selected 
metabolite features were the critical factors and metabolic pathway components that were 
correlated with various symptoms of CKD stages. These results also explained why these 
selected features could reconstruct better CKD stages diagnosis/classification models. 
Analyses of our selected metabolites features provided researchers with the opportunities 
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to gain new insights into metabolic profiling and pathophysiological mechanisms of the 
developments of CKD stages. Thus, our studies could be further used for CKD early stage 















CHAPTER 4  
DOWN SYNDROME PREDICTION AND SCREENING MODEL 
CONSTRUCTION USING DEEP LEARNING AND HUMAN 
GENOTYPING DATA 
4.1 MOTIVATIONS 
Down syndrome (DS) is a genetic disorder with genome dosage imbalances and 
micro-duplications of human chromosome 21. It is often associated with a group of serious 
diseases, including intellectual disability, cardiac diseases, physical abnormalities, and 
other abnormalities. Currently, there is no cure for human DS. Screening and early 
detection become the most efficient way of DS prevention. In this study, we will use deep 
learning techniques to construct an accurate CNN DS prediction/screening model from 
newly introduced Illumina exome genotyping array data. First, we will build the 
chromosome SNP maps from the clinical Illumina genotyping array data collected by 
Vanderbilt University Medical Center. Next, we will propose a CNN architecture with ten 
layers and two merged branch models that took two chromosome SNP maps as inputs. We 
will also perform three conventional supervised learning algorithms SVM, random forest 
and decision tree to construct the DS prediction/screening models with the same data. We 
will further evaluate and compare the performances of different models.  
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Finally, we will visualize the feature maps and the trained weight from the 
intermediate layers of the trained CNN model. We will further discuss the advantages of 
our method and the underlying reasons. 
4.2 METHODOLOGY 
4.2.1 Data  
In this study, we analyzed an Illumina exome genotyping array dataset that targeted 
rare single-nucleotide polymorphisms (SNPs). This genotyping dataset was collected by 
Vanderbilt University Medical Center. The dataset contained 378 samples, 315 non-DS 
patients and 63 DS patients. Each sample contained intensity information of total 5458 
SNPs from 321 HSA21 coding genes. For the CNN model construction, we built two 
chromosome SNP maps and used them as input images for each sample. Each chromosome 
SNP map represented intensities of all SNP site on one single chromosome of HSA21. 
Figure 4.1 shows the two input chromosome SNP maps for two HSA21 chromosomes. 
Columns of the chromosome SNP map represented all adjacent genes on the chromosome. 
Rows represented adjacent SNP sites within the same gene. Each pixel of chromosome 
SNP map represented the intensity of one SNP site from one gene. For conventional 
machine-learning model constructions, we used the original Illumina genotyping array 
dataset with 5458 SNPs features for model training and testing. All SNPs data were 
normalized into the interval [0,1]. To construct robust and reliable classification models, 
we generated ten parallel training and testing dataset by randomly selecting first 75% 
samples for training and rest for testing. Then we built ten parallel DS prediction/screening 
models and calculated average performance metrics to provide a systematic evaluation of 





Figure 4. 1 Chromosome SNP maps to represent the intensities of all SNP site on HSA21. 
Each column represents the information of one single gene located on the chromosome. 
Each row represents adjacent SNP sites within the same gene. Therefore, each pixel of the 
chromosome SNP map is used to represent the intensity of each SNP site of genes. 
 
4.2.2 Bi-steam CNN architecture.  
The Bi-stream CNN architecture constructed in this study was merged from two-
branch CNN models. Each branch model contained five layers, including one input layer, 
three convolutional layers, and one max pooling layer. Each branch model took one input 
chromosome SNP map. We further merged the two branches CNN model into one model 
in layer 6, which was another convolutional layer. Figure 4.2 showed the detailed structures 
of our CNN architecture. Detailed configurations were as the followings. Each branch 
model contained five layers:  
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Layer 1, the input layer took one grey image input of size 642x642 from one of the 
chromosome SNP maps.  
Layer 2, one 2D convolutional layer with 16 size 3*3 filters and ReLu activation.  
Layer 3, one 2D max pooling layer with 2*2 pool size to down-sample the data, followed 
by a dropout (0.25) to reduce overfitting.  
Layer 4, one 2D convolutional layer with 16 size 3*3 filters and ReLu activations, followed 
by dropout (0.25).  
Layer 5, one 2D convolutional layer with 16 size 3*3 filters and ReLu activations, followed 
by dropout (0.25).  
Next, in layer 6, we merged two previous branch CNN models into one convolutional layer 
with 16 size 3*3 filters and ReLU activations.  
Layer 7 was another 2D max pooling layer with 2*2 pool scale, followed by dropout (0.25). 
Layer 8 was a fully connected layer to flatten all 2D features into one-dimension.  
Layer 9 was a fully connected layer with 512 nodes and ReLU activation.  
Layer 10 was the output layer with two nodes and Softmax activation.  
The model was compiled with binary cross-entropy loss function and stochastic gradient 
descent optimizer (SGD), which had a learning rate of 0.01, 1e-6 decay and 0.9 nesterov 
momentum. CNN model construction and training were implemented with Keras and 
Tensorflow as the backend, using a NVIDIA GeForce GTX TITAN 12GB GPU on Ubuntu 









4.2.3 Conventional machine-learning algorithms.  
The random forest, SVM and decision tree algorithms were implemented by Python 
and Scikit Learn package (Pedregosa et al., 2011). Random forest algorithm had ten sub-
tree classifiers in the forest. Each sub-trees used Gini impurity and “entropy” to measure 
the quality of split of a feature. There was no limit on the maximum depth of each sub-tree 
until all leaves were pure or contained less than two samples. The decision tree was 
implemented by Classification and Regression Trees algorithm, which was similar to the 
C4.5 algorithm and constructed binary trees using the feature and threshold with the largest 
information gain at each node. It also used Gini impurity and “entropy” to measure the 
quality of split of a feature. The maximum number of features was set to the total number 
of features in the dataset. And there was no depth limit for the constructed models. The 
SVM algorithm was implemented by C-Support Vector Classification algorithm with "one-
vs-one" scheme. 
4.3 BI-STREAM CNN ARCHITECTURE 
Our Bi-stream CNN DS prediction/screening architecture extracted features from 
chromosome SNP maps that built from Illumina exome genotyping arrays. For each 
patient, we built two chromosome SNP maps from two different chromosomes of HSA21. 
Each pixel of the chromosome SNP map represented the intensity of one SNP site. Our 
CNN architecture took two chromosome SNP maps as input images and fed them into two 
branch models. Each branch model had one input layer, three convolutional layers and one 
max-pooling layer. Then we merged two branch models into one model in the fourth 
convolutional layer, which was followed by one max-pooling layer and three fully 
connected layers. All hidden layers were followed by dropouts to reduce overfitting. Figure 
 
 61 
4.3 showed the CNN architecture that used for human DS prediction/screening. Detailed 
CNN architecture construction and configurations were available in the Method section. 
 
Figure 4. 3 CNN architecture built for DS prediction/screening model construction using 
chromosome SNP maps. The upper CNN branch model and the lower CNN branch model 
both take one for the chromosome SNP map as the input image. Two CNN branch models 
merge into one model at the convolutional layer C4. Detailed CNN architecture 
construction and configurations are available in the Method section. 
 
4.4 BI-STREAM CNN DS PREDICTION/SCREENING MODEL CONSTRUCTION 
In this section, we used the Bi-stream CNN architecture (shown in Figure 4.3) to 
construct human DS prediction/screening models with Illumina genotyping array data. The 
genotyping array dataset contained 378 samples, including 63 DS patients and 315 non-DS 
patients. First of all, we normalized intensities of all SNPs into the interval [0,1]. Next, for 
each sample, we built two chromosome SNP maps from two chromosomes of HSA21. 
Columns of the chromosome SNP map represented adjacent genes on the chromosome. 
Rows represented adjacent SNP sites within the same genes. Each pixel represented the 
intensity of one SNP site of one gene. Then, we fed two input images into our CNN 
architectures at the same time for model training and testing. To build robust and reliable 
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classification models, we generated ten parallel training and testing dataset by randomly 
selecting the first 75% of samples for training and using the rest for testing. Then we built 
ten parallel DS prediction/screening models and calculated average performance metrics 
to provide a systematic evaluation. As shown in table 4.1, the DS prediction/classification 
models built on CNN architectures achieved an average accuracy of 99.3%. It also achieved 
very high scores on precision, recall, and F-score, which were 99.2%, 98.4%, and 99.3% 
respectively. It is worth to notice that the average false positive rate and false negative rates 
were only 0.6% and 1.1%. In all ten parallel experiments, only five samples with non-DS 
and two samples with DS in total were mis-predicted to the wrong classes. The above 
results demonstrated that we constructed an accurate CNN DS prediction/screening model, 
which could be further used for DS screening using illumina genotyping array data.  
 
Table 4. 1 Evaluation metrics of bi-stream CNN and conventional machine learning models. 
 
4.5 DS PREDICTION/SCREENING MODELS CONSTRUCTED FROM 
CONVENTIONAL SUPERVISED LEARNING ALGORITHMS. 
In this section, we evaluated and compared the performances of our CNN model 
and three conventional supervised learning algorithms. We generate ten parallel training 
and testing datasets by randomly selecting the first 75% data for training and the rest for 
testing. Next, we used the original Illumina genotyping array data with total 5458 SNP 
features to construct DS prediction models by support vector machine (SVM), random 
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forest, and decision tree algorithms. Learning algorithms, model constructions and 
configurations were implemented by Scikit Learn package (Pedregosa et al., 2011), which 
were available in the Methods section. Finally, we evaluated and compared the 
performances of these three conventional supervised learning algorithms and our CNN 
model. As Table 4.1 shown, models built from SVM, random forest and decision tree could 
achieve over 96% average accuracies. The random forest model achieved the best 
performance over all three conventional supervised learning models, which had an average 
accuracy of 97.1%. The SVM model had the worst performance with an average accuracy 
of 96.7%. Decision tree’s performance was between the other two models with an average 
accuracy of 96.9%. However, table 4.1 also showed that our CNN models achieved higher 
average accuracy (99.3%) than all three conventional learning algorithms. The CNN model 
also produced higher average precisions, recalls, and F-scores. Even though the three 
conventional models achieved good accuracy sores, their false negative rates were very 
high, which were 5.3%, 8.1%, and 8.0% respectively. Their high false negative rates made 
them hard to be put into practice. Our CNN DS prediction/screening models only had an 
average false negative rate of 1.1% and a false positive rate of 0.6%. In this section, our 
CNN models had notably better performances in all evaluating metrics than other 
conventional learning models. 
4.6 COMPARING WITH SINGLE-STREAM CNN MODEL. 
In this section, we built two new single-stream CNN models using the same 
configurations and datasets with our bi-stream CNN model proposed above. The difference 
between bi-stream and single-stream CNN models was that single stream model only had 
one CNN branch and took one chromosome SNP map as the input image. We further 
compared and evaluated the performances of two single-stream CNN models. As Table 4.2 
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shown, our bi-stream CNN model achieved the best performance over all three models in 
all evolutionary metrics. The other two single-stream CNN model also achieved over 96% 
accuracies. However, the recall of the first single-stream model and the precision of the 
second single-stream model were very low, which were 84.0% and 88.7% respectively. 
Furthermore, the false positive and false negative rate of the single-stream CNN models 
were significantly higher than the bi-stream CNN model. In general, our bi-stream CNN 
model had significantly better performances than the single-stream CNN models. The 
single-stream models could only extract the genome features from one single chromosome, 
which completely neglected the genomic patterns from the other one. Therefore, they were 
not as accurate as the bi-stream CNN model. The bi-stream CNN model was more 
comprehensive, accurate, and reliable when compared with the single-stream DS 
prediction models. 
 
Table 4. 2 Evaluation metrics of different CNN models. 
 
 
4.7 VISUALIZATION OF FEATURE MAPS AND TRAINED FILTERS OF BI-
STREAM MODEL 
In this section, we visualized the trained filters and feature maps from intermediate 
convolutional hidden layers of our trained bi-stream CNN model. The bi-stream CNN 
model had a few advantages when compared with traditional machine learning algorithms. 
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First of all, we used chromosome maps to represent the genotyping array information, 
which converted one-dimensional genome data to images. Secondly, we used 16 
convolutional 3x3 size kernels to capture local genomic features and detect patterns from 
adjacent genes and SNP sites from two chromosome SNP maps. Thirdly, two-branch CNN 
model could capture the genomic features from two chromosomes at the same time. Figure 
4.4 A and B showed the output feature maps and their corresponding trained filters from 
convolutional layer C1 of each branch CNN models. Some trained filters could highlight 
the most important and informative SNP sites from the chromosome SNP maps, and 
neglect less informative ones (marked as yellow squares). The green rectangles showed 
that our trained filters could sharpen input images and capture local motifs, which 
represented the correlated variations patterns in genome regions. The bi-stream model 
could also detect continuous gene and SNP intensity variations by capturing adjacent 
variation patterns in line (marked as white rectangles).  
Our bi-stream CNN model could detect the simultaneous or causal SNPs variations 
in human genomes. These genome characterizations and extracted genomic patterns 
provided signals to classify DS and normal samples. However, traditional machine learning 
algorithms tended to build models with a global view from all available features and treated 
each feature independently. Therefore, they were hard to extract signals from regional 





Figure 4. 4 Visualization of feature maps and trained filter weights from convolutional 
layer C1 of Figure 4.3. Figure a, b, c and d in figure (A) represent four feature maps from 
convolutional layer C1 of lower branch CNN model (shown in Figure1). Figure e, f, g, and 
h in figure (A) are the corresponding 3x3 kernels weights of Figure a, b, c, and d. Figure a, 
b, c and d in Figure (B) represent four feature maps from convolutional layer C1 of the 
upper branch CNN model. Figure e, f, g, and h in figure (B) are the corresponding 3x3 
kernels weights for Figure a, b, c, and d. 
 
4.8 DISCUSSION 
Previous studies illustrated that gene expressions and SNP variations were highly 
correlated within local genome regions (Bulik-Sullivan et al., 2015; Duerr et al., 2006; Farh 
et al., 2015). Genome-wide association studies also demonstrated that human DS was 
usually associated with many gene copy number and SNPs variations, and many 
unidentified genomic abnormalities (Jain et al., 2016; Petry et al., 2017; Sailani et al., 2013). 
In this study, our bi-stream CNN model could learn the genomic features and associated 
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variations among adjacent genes and SNP sites from chromosome SNP maps. Currently, 
human DS treatments only have limited effects. They cannot cure DS fundamentally either. 
At the same time, there isn’t any clear effect or benefit on human DS treatments by using 
traditional drugs (K. J. Gardiner, 2015; Kishnani et al., 2010; Lott et al., 2011; Mohan, 
Bennett, & Carpenter, 2009). The feature maps and extracted genome features could 
identify DS related markers and pathway components. These genome features explained 
the genomic characteristics and pathological mechanisms of human DS, which could be 
further applied in gene therapy and genetic medicine developments. 
 
An accurate non-invasive DS screening method offers a low-risk way to screen 
human DS. It helps low-risk patients avoid taking further invasive diagnostic procedures, 
which could result in fetal loss. Nowadays, genotyping array analyses on fetal genomes 
could be performed on the trophoblast cells with non-invasive procedures after the fifth 
week gestation (Jain et al., 2016; Petry et al., 2017). In this study, we developed a novel 
method to construct accurate DS screening model by using bi-stream CNN and genotyping 
array data. The results showed that our bi-stream CNN model had the best performance in 
every evaluation metric when compared with two single-stream CNN models and three 
traditional machine learning models. The CNN model achieved over 99.3% accuracies, as 
well as very low false positive and false negative rates. It was very important to disease 
prediction and medical practice. Even though traditional machine learning algorithms 
obtained over 96% accuracies. Their high false-negative rates are not suitable for clinical 
screening tests. Traditional machine learning algorithms treated each SNP sites as single 
feature independently. They were hard to extract signals from regional genomic patterns 
and variation correlations between adjacent genes and SNPs sites. Although the single-
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stream models could extract features and patterns from local genome features and adjacent 
SNP sites, they could only learn these features from one single chromosome, which 
completely neglected the genomic patterns of the other one. In deep learning studies, large 
datasets were great obstacles in the model construction and optimization. We used each 
pixel to represent the intensities of SNP site, and used chromosome SNP maps to represent 
the genome information, which significantly reduced data and model complexity. 
Furthermore, our bi-stream CNN architecture could learn local genomic patterns and 
extracted regional features, which could also be applied to build prediction models from 
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